CNTB - CIK 0001835268
Connect Biopharma Holdings Ltd has filed 180 documents with the SEC between 2020 and 2026. The most frequent type is 6-k (49 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| F-3 | - | 2026-05-15 | - |
| Quarterly report | 10-Q | 2026-05-12 | 2026-03-31 |
| Major company event | 8-K | 2026-05-12 | 2026-05-12 |
| Major company event | 8-K | 2026-04-23 | 2026-04-23 |
| SCHEDULE 13G | - | 2026-04-14 | - |
| Insider trade | 4 | 2026-04-02 | 2026-03-31 |
| Insider trade | 4 | 2026-04-02 | 2026-03-31 |
| SCHEDULE 13D/A | - | 2026-04-01 | - |
| Insider trade | 4 | 2026-04-01 | 2026-03-31 |
| Annual report | 10-K | 2026-03-31 | 2025-12-31 |
| Major company event | 8-K | 2026-03-31 | 2026-03-31 |
| Major company event | 8-K | 2026-03-30 | 2026-03-29 |
| New insider ownership | 3 | 2026-03-18 | 2026-03-18 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| New insider ownership | 3 | 2026-03-16 | 2026-03-16 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G | - | 2026-02-17 | - |
| Major company event | 8-K | 2025-12-23 | 2025-12-17 |
| SCHEDULE 13G/A | - | 2025-11-28 | - |
| SCHEDULE 13D/A | - | 2025-11-26 | - |
| Insider sale notice | 144 | 2025-11-24 | - |
| Insider sale notice | 144 | 2025-11-21 | - |
| Insider sale notice | 144 | 2025-11-18 | - |
| Quarterly report | 10-Q | 2025-11-12 | 2025-09-30 |
| Major company event | 8-K | 2025-11-12 | 2025-11-12 |
| Insider sale notice | 144 | 2025-10-01 | - |
| Major company event | 8-K | 2025-09-16 | 2025-09-16 |
| EFFECT | - | 2025-09-12 | - |
| POS AM | - | 2025-09-10 | - |
| Quarterly report | 10-Q | 2025-08-13 | 2025-06-30 |
| Major company event | 8-K | 2025-08-13 | 2025-08-13 |
| Major company event | 8-K | 2025-07-22 | 2025-07-22 |
| Major company event | 8-K | 2025-07-21 | 2025-07-18 |
| SCHEDULE 13D/A | - | 2025-07-21 | - |
| F-6 POS | - | 2025-07-18 | - |
| Major company event | 8-K | 2025-07-17 | 2025-07-16 |
| Major company event | 8-K | 2025-07-09 | 2025-07-09 |
| EFFECT | - | 2025-06-26 | - |
| Company correspondence | CORRESP | 2025-06-24 | - |
| SEC correspondence | UPLOAD | 2025-06-12 | - |
| Insider sale notice | 144 | 2025-06-11 | - |
| Employee stock plan | S-8 | 2025-06-10 | - |
| F-3 | - | 2025-06-10 | - |